PRESS RELEASE published on 03/19/2025 at 07:30, 1 year ago Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étude de phase 3b Whistler sur le NCX 470 pour le glaucome Nicox annonce la fin de la visite du dernier patient dans l'étude de phase 3b Whistler sur le NCX 470 pour le glaucome. Résultats attendus en mai 2025 Étude Clinique Nicox NCX 470 Glaucome Phase 3b
BRIEF published on 01/28/2025 at 07:35, 1 year 2 months ago Nicox : Participation aux Grands Congrès en 2025 Investissement Ophtalmologie Congrès Nicox NCX 470
BRIEF published on 01/28/2025 at 07:35, 1 year 2 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 2 months ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 2 months ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 2 months ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour les 12 prochains mois, ouvrant la voie à l'investissement dans les petites et moyennes valeurs en ophtalmologie. Pour plus d'informations, consultez www.nicox.com PEA-PME Investissement Éligibilité Ophtalmologie Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 2 months ago Nicox : Résumé financier et activités du quatrième trimestre 2024 Résultats Financiers Trésorerie Nicox NCX 470 Quatrième Trimestre 2024
BRIEF published on 01/21/2025 at 07:35, 1 year 2 months ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
Published on 04/02/2026 at 22:00, 1 day 9 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 12 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 16 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 16 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 16 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 02:05, 5 hours 4 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 13 hours 9 minutes ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 13 hours 9 minutes ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 13 hours 24 minutes ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:40, 13 hours 29 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.04.26.
Published on 04/03/2026 at 18:46, 12 hours 22 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 12 hours 22 minutes ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 13 hours 7 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 13 hours 9 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 13 hours 9 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
